STEADYBIT
Today, Steadybit is thrilled to announce the launch of its latest feature, Landscape Explorer. Aimed squarely at modern DevOps and SRE teams, Landscape Explorer is designed to guide users through the maze of their system landscapes, making the planning and execution of Chaos Engineering experiments more straightforward.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20231017355046/en/
Exploring the correlation between microservice needs and API endpoints reveals key infrastructure components. By sizing targets based on Spring MVC mappings, we highlight the importance of high availability and Chaos Engineering. (Graphic: Business Wire)
Addressing a Pressing Need
Landscape Explorer helps tackle the complexity of evolving infrastructure, which often stymies teams using traditional methods in their Chaos Engineering experiments.
Landscape Explorer: Your Visual Guide
Built on Steadybit's proven target discovery technology, the Landscape Explorer offers a visual overview of all infrastructure components. Its default view displays a detailed Cluster map, allowing users to quickly grasp their system's architecture. Customization options, such as filtering and grouping, give users unparalleled insights, easing the planning process for Chaos Engineering experiments.
Actionable Insights for Real-World Scenarios
The Landscape Explorer goes beyond mere visualization. It provides actionable data, such as identifying deployments across multiple availability zones and pinpointing business-critical components.
Extend and Enrich
Organizations can augment Explorer's data through Extension Kits, allowing for more nuanced and detailed system exploration.
Feature Highlights:
- In-depth Insights: Customizable visual maps guide users in navigating complex systems, simplifying decision-making.
- Automatic Discovery: This feature keeps pace with the complexity of modern infrastructures, continuously updating and describing system components for precise experimentation.
- Open-Source Integration: Steadybit encourages community input, ensuring the Landscape Explorer continually evolves.
“The Landscape Explorer is a great tool to view the cloud resources in your account and within the Kubernetes clusters. The interactive visualization, table view, and capability to explore with filters is great.” - Krishna Palati, Director of Software Development at Salesforce.com.
Steadybit remains steadfast in its commitment to innovation and continuous improvement. As part of this ongoing effort, the company plans to continue enhancing the Landscape Explorer, driven by invaluable user feedback. Through these updates, Steadybit aims to offer an ever-more powerful tool that meets the evolving needs of DevOps and SRE teams worldwide.
For a detailed walkthrough of the Landscape Explorer and to dive deep into its capabilities, please check out Steadybit's blog post: Launching Explorer: Your Companion on the Chaos Engineering Journey.
About Steadybit: Steadybit offers leading-edge Chaos Engineering solutions. With a focus on delivering a user-friendly experience packed with actionable insights, Steadybit is quickly becoming the preferred choice for DevOps and SRE teams around the globe.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20231017355046/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
AwardFares Launches Intelligent New Alert System for Award Flight Availability5.8.2025 08:00:00 CEST | Press release
AwardFares, the leading search platform for award flights, today launched a major upgrade to its alert system, giving users smarter tools to discover and book award availability faster. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250804412041/en/ AwardFares' Timeline view provides a clear, color-coded visualization of daily award seat availability across different cabin classes, helping users easily spot trends and opportunities for flights. The new system includes two powerful features: Flex Alerts and Live Alerts. Together, they provide both flexibility and precision, helping travelers maximize their points and miles like never before. Flex Alerts are designed for the flexible traveler. Instead of requiring an exact route and date, users can set broad criteria such as "any airport in the US to Europe for an entire month.” AwardFares' AI-powered system intelligently identifies matching availability, focusing not just on
Venture Global Calcasieu Pass Receives Uprate Approval from U.S. Department of Energy5.8.2025 02:02:00 CEST | Press release
Today, Venture Global, Inc. (NYSE: VG) received approval from the U.S. Department of Energy (DOE) for an uprate amendment to its Calcasieu Pass LNG project. The uprate approval increases Calcasieu Pass’ permitted peak liquefaction capacity from 12.0 million tonnes per annum (MTPA) to 12.4 MTPA. “Venture Global thanks its regulators, including DOE, for their efforts in prioritizing and streamlining approvals for critical energy infrastructure projects. These multibillion dollar investments will be key as the United States strengthens global energy security and increases energy trade with our partners around the world,” said Venture Global CEO Mike Sabel. Calcasieu Pass, Venture Global’s first project, reached first LNG production in 2022 and began commercial operations in April 2025. The company’s second facility, Plaquemines LNG, began LNG production in December 2024. Venture Global’s third project, CP2, received DOE export authorization and FERC approval in March 2025 and May 2025, re
Vertex Announces Results from Phase 2 Study of VX-993 for the Treatment of Acute Pain4.8.2025 22:01:00 CEST | Press release
– Treatment with the selective NaV1.8 pain signal inhibitor VX-993 after bunionectomy surgery did not meet the primary endpoint –– Treatment with VX-993 was generally safe and well tolerated, with safety profile similar to placebo arm – Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced topline results from its recently completed Phase 2, randomized, double-blind, placebo-controlled dose-ranging study evaluating the safety and efficacy of its investigational selective NaV1.8 pain signal inhibitor, VX-993, in treating acute pain after bunionectomy surgery. Treatment with VX-993 did not result in a statistically significant improvement on the primary endpoint of the time-weighted Sum of the Pain Intensity Difference from 0 to 48 hours (SPID48) compared to placebo. VX-993 was generally safe and well tolerated. Most adverse events (AEs) were mild to moderate, and there were no serious adverse events (SAEs) related to VX-993. Based on these results, Vertex will not progress
TOURISE Announces Cross-Sector Advisory Board to Champion Bold New Platform Rewriting the Rules of Tourism4.8.2025 20:53:00 CEST | Press release
Leaders from World Travel & Tourism Council (WTTC), Global Sustainable Tourism Council, Amadeus, TikTok, Six Senses, Cirque du Soleil, Turismede Barcelona, Liberty International, Wagonlit Travel, Once Billion Happy, the Saudi Tourism Authority (STA), and the Riyadh School of Tourism and Hospitality at the helm of TOURISE Advisory Board Formation of the Advisory Board reinforces TOURISE’s dedication to driving cross-sector global collaboration Advisory Board shape TOURISE summit agenda, ensuring high-impact global issues such as equity, geographical representation and sectoral diversity are in spotlight TOURISE, the bold new global tourism platform, has announced the members of its cross-sector Advisory Board, a powerhouse of industry titans guiding TOURISE’s strategic direction and shaping the agenda of the inaugural global summit taking place in Riyadh from 11-13 November, 2025. TOURISE is where cross-sector convergence begins, a platform where leaders and visionaries debate, collabor
Concept Medical Announces First Patient Enrollment in MAGICAL-SV IDE Trial, Expanding its Coronary Clinical Program Across the U.S. and Europe4.8.2025 20:38:00 CEST | Press release
Concept Medical Inc., a global pioneer in drug-delivery technologies, announced the enrollment of the first patient in the MAGICAL-SV (MAGIcTouch™ Sirolimus-Coated Balloon for Treatment of Coronary Artery Lesions in Small Vessels) trial, a U.S. Investigational Device Exemption (IDE) study evaluating its MagicTouch™ sirolimus-coated balloon (SCB) for the treatment of small coronary vessels. This first U.S. enrollment follows the FDA’s IDE approval of MagicTouch SCB, marking a major milestone in Concept Medical’s mission to revolutionize coronary artery disease (CAD) treatment and expand its clinical program into the US and Europe. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250804524652/en/ Concept Medical Announces First Patient Enrollment in MAGICAL-SV IDE Study Dr. Samin Sharma enrolled the first patient at New York’s Mount Sinai Hospital, Director of Interventional Cardiology, marking a crucial step in advancing treatm
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom